A method for preparing compound Phellibaumin D from Phellinus igniarius medicinal material

Through the combination of two-dimensional liquid chromatography and specific silica gel fillers, the extraction and purification efficiency of the compound Phellibaumin D in mulberry medicinal materials has been successfully improved, solving the problem of limited purity and application, and achieving high purity preparation and good Repeatability and yield, suitable for large-scale production.

CN114573539BActive Publication Date: 2024-11-05DALIAN INSTITUTE OF CHEMICAL PHYSICS CHINESE ACADEMY OF SCIENCES
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202011398708.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2020-12-02
Publication Date
2024-11-05
Estimated Expiration
2040-12-02

AI Technical Summary

Technical Problem

The compound Phellibaumin D is relatively rare among mulberry medicinal materials, and there is a lack of relevant pharmacological activity literature reports. The preparation of this compound is of great significance to basic research and pharmacological activity research, but it is difficult to effectively extract and purify the existing technology, resulting in limited purity and application.

Method used

Using two-dimensional liquid chromatography technology, combined with ethanol water extraction, ceramic membrane filtration and different types of silica gel fillers, the high-purity extraction and purification of the compound Phellibaumin D is achieved through gradient elution and high-density bonding of C18TDE silica gel fillers, reaching 90%. The above purity.

Benefits of technology

The extraction rate and purity of the compound Phellibaumin D are improved, impurity contamination of hydrolysate is avoided, and high purity is achieved. It has good repeatability and high yield. It is suitable for large-scale production and simplifies the operation process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0002811733780000021
    Figure BDA0002811733780000021
  • Figure BDA0002811733780000031
    Figure BDA0002811733780000031
  • Figure HDA0002811733790000011
    Figure HDA0002811733790000011
Patent Text Reader

Abstract

The present invention provides a method for preparing compound Phellibaumin D from Phellinus igniarius medicinal materials, wherein the Phellibaumin D medicinal materials are extracted with ethanol water, and a two-dimensional orthogonal technique of preparative chromatography is adopted, wherein a crude product of compound Phellibaumin D is obtained by enriching with pure water-resistant C18YE silica gel filler in one dimension, and a high-density bonded C18TDE silica gel filler is used in the second dimension for preparation and purification, so as to obtain compound Phellibaumin D with a purity of more than 90%. The preparation process of the present invention has good repeatability, the solvent can be recycled, the yield is high, the degree of automation is high, the operation is easy, and the demand for large-scale production can be met.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The method relates to the field of separation and purification technology, and specifically is a method for preparing compound Phellibaumin D from Phellinus igniarius. Furthermore, the present invention is a method for preparing high-purity compound Phellibaumin D from Phellinus igniarius using two-dimensional liquid chromatography technology, and the purity can reach more than 90%. Background Art

[0002] Phellinus igniarius is a precious perennial large-scale medicinal fungus, known as the "forest gold" and recorded in the Compendium of Materia Medica. It belongs to the genus Aciliophora, Polyporaceae, Polyporaceae, Basidiomycetes, and has 40 species distributed in my country. It mainly parasitizes on the trunks of mulberry, willow, birch, poplar and oak trees, among which wild mulberry igniarius is the most precious.

[0003] As a traditional Chinese medicine of fungi, Phellinus igniarius is currently internationally recognized as the most effective medicinal fungus in the field of biological cancer treatment. It contains chemical components of various structural types, including polysaccharides, flavonoids, triterpenes, aromatic acids, amino acids, etc. Modern pharmacological experiments have also shown that Phellinus igniarius has multiple pharmacological activities such as anti-cancer, immunomodulatory, anti-obesity, antioxidant and anti-inflammatory.

[0004] Phellinus igniarius can metabolize and produce many kinds of hispidin derivatives, which are believed to be produced by the oxidative coupling of hispidin precursors and polyphenolic compounds under the catalysis of oxidase. The main ones are hispidin skeleton and benzopyrone skeleton. In the past ten years, there have been many studies on phellin igniarius polyphenolic compounds at home and abroad, and many new compounds have been discovered. Moreover, many of these compounds have been reported with novel skeletons. These compounds have antioxidant and free radical scavenging activities, and have antioxidant, antiviral, anti-lipid, and Alzheimer's disease mitigation effects.

[0005] Based on the hypothesis of the biosynthetic pathway of Hispidin compounds proposed by predecessors. There are literature reports proposing the possible biosynthetic pathway of Phellibaumins AD. Phellibaumin B and Phellibaumin D may be produced by the coupling of one Hispidin molecule and one caffeic acid molecule, but different oxidation methods produce two different compounds. Phellibaumin D reacts with ethanol to produce Phellibaumin E. Phellibaumin C is likely to be the precursor of Phelligridin H. Phellibaumin A may be derived from Phelligridin D removing a molecule of CO.

[0006]

[0007] Phellibaumin D is a golden yellow powder with the following structural formula:

[0008]

[0009] The compound Phellibaumin D is rarely reported, there is no literature report on its pharmacological activity, and the spectrum-effect relationship is unclear. Therefore, the preparation of this compound is of great significance to the basic research and pharmacological activity research of Phellibaumin.

[0010] In view of the above technical background and development prospects, the present invention is proposed. Summary of the invention

[0011] The present invention provides a method for preparing compound Phellibaumin D by using phellinus igniarius as raw material and adopting two-dimensional liquid chromatography, and the operation steps are as follows:

[0012] 1. Preferably, the extraction of Phellinus igniarius medicinal materials is carried out by alcohol extraction with 60-80% ethanol water, the solid-liquid ratio is 1:15-50, soaking for 10-24 hours, heating water extraction for 1-3 hours, extracting 2-3 times, and combining to obtain an alcohol extract;

[0013] 2. Preferably, the alcohol extract is filtered through a ceramic membrane using a membrane filtration technique, the pore size of the ceramic membrane filter is 200-500 nm, and the permeate is concentrated to a concentration of 10-100 mg / mL;

[0014] 3. As a preferred method, the one-dimensional chromatographic filler used is pure water-resistant C18YE silica gel filler, which has a good enrichment effect on the compound Phellibaumin D. The filler has a particle size of 30 to 60 μm and a pore size of 80 to 100 μm. , enriched to obtain the crude compound Phellibaumin D;

[0015] 4. In order to achieve the purpose of one-dimensional preparation of enriched compound Phellibaumin D crude product, the present invention adopts the following preparation scheme:

[0016] The elution conditions used in the preparation are: methanol or ethanol (organic phase) is mixed with formic acid water or oxalic acid water (aqueous phase), according to the organic phase 50-70% gradient, the aqueous phase is formic acid or oxalic acid with a ratio of 0.1-1.5% (v / v), the flow rate is 0.1-0.2 times the filler volume / min, the temperature is 20-40°C, the sample loading is 0.5-1.0% (ratio of sample liquid solid mass to filler mass), the detector is a DAD ultraviolet detector, the elution time is 50-80min, the fractions are collected according to the detector chromatographic peak curve, all the fractions are subjected to liquid phase analysis, the Phellibaumin D fraction is confirmed, and the fractions are concentrated to 10-50 mg / mL after merging to obtain a one-dimensional enriched Phellibaumin D crude product;

[0017] 5. Preferably, the two-dimensional preparation uses high-density bonded C18TDE silica gel filler with a filler particle size of 5 to 20 μm and a pore size of The compound Phellibaumin D was prepared with a purity of >90%;

[0018] 6. In order to achieve the purpose of preparing the compound Phellibaumin D in two dimensions, the present invention adopts the following preparation scheme:

[0019] The two-dimensional liquid chromatography preparation adopts the elution condition of methanol or ethanol (organic phase) mixed with formic acid water or oxalic acid water (aqueous phase), according to the organic phase 50-70% gradient or step isocratic, the aqueous phase is formic acid or oxalic acid ratio of 0.1-0.8% (v / v), the flow rate is 0.2-0.3 times the filler volume / min, the temperature is 20-40°C, the sample loading is 0.2-0.4% (ratio of sample liquid solid mass to filler mass), the detector is a DAD ultraviolet detector, the elution time is 30-60min, the components of Phellibaumin D are collected according to the detector chromatographic peak curve, and the obtained fractions are vacuum dried to obtain the compound Phellibaumin D with a purity of more than 90%.

[0020] The present invention has the following advantages:

[0021] Compared with the prior art, the present invention has the following characteristics:

[0022] 1. The extraction method of ethanol water for Phellinus igniarius can better extract weak polar substances, and the extraction rate of the target compound Phellibaumin D is higher.

[0023] 2. The one-dimensional preparation and enrichment adopts pure water-resistant C18YE silica gel filler, which can load large volumes of pure water phase samples and has a good enrichment effect on the compound Phellibaumin D, avoiding the curling of the bonded phase and loss of retention of ordinary C18 bonded fillers; the two-dimensional preparation adopts high-density bonded C18TDE silica gel filler, which has a good retention of the compound Phellibaumin D, and also has good orthogonality and complementarity with the one-dimensional preparation, which can remove more impurities.

[0024] 3. The compound Phellibaumin D obtained through two-dimensional preparation has high purity: Due to the technical method used in the present invention, the compound Phellibaumin D contained in the medicinal material is directly prepared without heating or acid-base changes. The compound Phellibaumin D is prepared in the state existing in the medicinal material itself without being doped with hydrolysis products. Therefore, the obtained compound Phellibaumin D has high purity, reaching more than 90%.

[0025] 4. The method for preparing the compound Phellibaumin D involved in the present invention has good repeatability, high yield, recyclable solvent, simple operation, high degree of instrument automation, and can meet the needs of large-scale production. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 is a one-dimensional preparation spectrum of the compound Phellibaumin D of Example 1;

[0027] Figure 2 is the two-dimensional preparation spectrum of the compound Phellibaumin D of Example 1;

[0028] Figure 3 This is the liquid phase analysis spectrum of the compound Phellibaumin D in Example 1. DETAILED DESCRIPTION

[0029] The present invention is further described in conjunction with examples. It should be noted that, for those skilled in the art, several improvements and modifications can be made without departing from the technical principles of the present invention, and these improvements and modifications should also be considered as the protection scope of the present invention. The examples are limited to illustrating the present invention, and the present invention is not limited thereto.

[0030] Example 1

[0031] Weigh 100g of Phellinus igniarius medicinal material, add 3L of 70% ethanol aqueous solution, and soak for 24 hours; then heat and boil for 8 hours, collect the alcohol extract, add 3L of aqueous solution to the solid material again, add water and boil repeatedly, collect the alcohol extract, and obtain the mulberry igniarius medicinal material alcohol extract solution, filter with a ceramic membrane, the pore size of the ceramic membrane core is 100nm, and the permeate is concentrated to 20mg / mL to obtain the ceramic membrane permeate concentrate.

[0032] The first-dimensional preparation conditions and chromatographic conditions were C18YE filler (preparative column specifications: 100×250 mm, particle size 30 μm, pore size The mass was 1200 g, Huapu Xinchuang Technology Co., Ltd.), the mobile phase was (A) methanol (organic phase)-(B) 0.1% formic acid water (aqueous phase, v / v), and the gradient elution method was as follows: the volume concentration of methanol (mobile phase A) was increased from 50% to 60% over 60 min (the rest was mobile phase B) and the gradient elution was performed for 60 min. The DAD ultraviolet detector was used to select the absorption wavelength at 254 nm. The preparation temperature was 25°C, the injection volume was 300 mL / needle, the sample loading was 0.6% (the ratio of the solid mass of the sample solution to the mass of the filler), the mobile phase flow rate was 300 mL / min, and the fractions were collected according to the chromatographic peak curve of the detector. All the fractions were subjected to liquid phase analysis to confirm the Phellibaumin D fraction, which was combined and concentrated to 50 mg / mL to obtain a crude one-dimensional prepared compound Phellibaumin D with a purity of 36.51% and a yield of 86.9%.

[0033] Two-dimensional preparation conditions, chromatographic conditions using high-density bonded C18TDE silica gel filler (preparative column specifications: 50×250mm, particle size 10μm, pore size The mass was 300 g, Huapu Xinchuang Technology Co., Ltd.), the mobile phase was (A) ethanol (organic phase)-(B) containing 0.1% formic acid water (aqueous phase, v / v, 55% ethanol (mobile phase A) was used for isocratic elution (the rest was mobile phase B), the DAD ultraviolet detector was used to select the absorption wavelength at 254 nm, the preparation temperature was 25°C, the injection volume was 20 mL / needle (the concentration of the concentrate prepared in one dimension was 50 mg / mL), the mobile phase flow rate was 60 mL / min, and the fractions of Phellibaumin D were collected according to the chromatographic peak curve of the detector (collected according to the chromatographic peak), and the product was rotary evaporated to dryness to obtain the compound Phellibaumin D (the product was determined to be the compound Phellibaumin D by nuclear magnetic resonance and high-resolution mass spectrometry structure analysis), and the purity was 93.55% and the yield was 91.1% after liquid chromatography analysis.

[0034] Example 2

[0035] Weigh 100g of Phellinus igniarius medicinal material, add 2L of 50% ethanol aqueous solution, and soak for 36 hours; then heat and boil the water for 6 hours, collect the alcohol extract, add 2L of 50% ethanol aqueous solution to the solid material again, boil and extract, collect the alcohol extract, combine the alcohol extract, filter it with a ceramic membrane, the pore size of the ceramic membrane core is 100nm, and concentrate the permeate to 30mg / mL.

[0036] One-dimensional preparation conditions, chromatographic conditions using pure water resistant C18YE silica gel filler (preparative column specifications: 100 × 250 mm, particle size 60 μm, pore size The mass was 1200 g, Huapu Xinchuang Technology Co., Ltd.), the mobile phase was (A) ethanol (organic phase)-(B) 0.1% oxalic acid water (aqueous phase, v / v), the step isocratic elution mode was: pure water elution for 20 min, ethanol (mobile phase A) volume concentration 55% isocratic (the rest was mobile phase B) elution for 60 min, DAD ultraviolet detector 254 nm was used to select the absorption wavelength, the preparation temperature was 20°C, the injection volume was 300 mL / needle, the sample loading was 0.75% (the ratio of the solid mass of the sample solution to the mass of the filler), the mobile phase flow rate was 300 mL / min, and the fractions were collected according to the chromatographic peak curve of the detector. All fractions were subjected to liquid phase analysis to confirm the Phellibaumin D fraction, which was combined and concentrated to 20 mg / mL to obtain a crude one-dimensional prepared compound Phellibaumin D with a liquid phase analysis purity of 46.82% and a yield of 90.1%.

[0037] Two-dimensional preparation conditions, chromatographic conditions using high-density bonded C18TDE filler (preparative column specifications: 50×250mm, particle size 10μm, pore size The mass was 300 g, Huapu Xinchuang Technology Co., Ltd.), the mobile phase was (A) methanol (organic phase) - (B) 0.5% oxalic acid water (aqueous phase, v / v), and the volume concentration was increased from 50% methanol (mobile phase A) to 65% methanol (the rest was mobile phase B) for gradient elution in 60 min, and the absorption wavelength was selected at 254 nm using a DAD ultraviolet detector. The preparation temperature was 15 ° C, the injection volume was 20 mL / needle, and the mobile phase flow rate was 60 mL / min. The fractions of Phellibaumin D were collected according to the chromatographic peak curve of the detector (collected according to the chromatographic peak), and the product was rotary evaporated to dryness to obtain the compound Phellibaumin D (the product was determined to be the compound Phellibaumin D by nuclear magnetic resonance and high-resolution mass spectrometry structure analysis), and the purity was 92.68% and the yield was 93.5% after liquid chromatography analysis.

[0038] Comparative Example 1

[0039] The difference from Example 1 is that non-group-modified silica gel (100-200 mesh) is used as the separation material, and other conditions are the same as Example 1. The crude product of Phellibaumin D cannot be enriched, so two-dimensional preparative separation and purification cannot be performed, and the high-purity compound Phellibaumin D cannot be obtained.

[0040] Comparative Example 2

[0041] The difference from Example 1 is that pure water is used to extract the medicinal material Phellibaumin, and the other conditions are the same as in Example 1. The water extract is filtered and concentrated through a ceramic membrane, and the crude compound Phellibaumin D is obtained through one-dimensional preparative enrichment with a purity of 36.82% and a yield of 50.1%. After two-dimensional preparative separation and purification, the compound Phellibaumin D has a purity of 54.1% and a yield of 61.82%.

[0042] Comparative Example 3

[0043] The difference from Example 1 is that the one-dimensional separation filler uses ordinary octadecylsilane bonded silica gel, and the other preparation conditions are the same. The crude compound Phellibaumin D is prepared in one dimension, and the liquid phase analysis purity is 36.38%, and the yield is 40.1%.

[0044] The two-dimensional separation filler is ordinary octadecylsilane bonded silica gel, and the other preparation conditions are the same. After liquid chromatography analysis, the purity is 71.32% and the yield is 66.1%.

Claims

1. A method for preparing compound Phellibaumin D from Phellinus igniarius medicinal material, comprising the following steps: (1) extracting the medicinal material of Phellinus igniarius by boiling it in ethanol and water to obtain an alcohol extract of Phellinus igniarius; (2) filtering the alcohol extract of Morinda tinctoria through a ceramic membrane to obtain a ceramic membrane permeate, and then concentrating the filtered liquid to obtain a ceramic membrane permeate concentrate; (3) Using pure water-resistant C18YE silica gel filler, the ceramic membrane permeated concentrate was enriched in one dimension to obtain the crude compound Phellibaumin D; the chromatographic filler used was pure water-resistant C18YE silica gel filler, and the elution conditions were one or two organic phases of methanol and ethanol and acid water as the aqueous phase as the mobile phase, the aqueous phase was one or two of formic acid or oxalic acid, the volume ratio was 0.05-5.0%, according to the organic phase 20-80% isocratic, 20-80% linear gradient or step gradient, the flow rate was 0.05-1.5 times the filler volume / min, the temperature was 10-60°C, the sample loading was 0.1-8.0%, the detector was a DAD ultraviolet detector, the elution time was 10-200 min, and the fractions were collected according to the detector chromatographic peak curve, and all the fractions were subjected to liquid phase analysis to confirm the Phellibaumin D fraction, and then the fractions were combined and concentrated to 20-200 mg / mL for the one-dimensional preparation of Phellibaumin D crude product; the chromatographic filler C18YE silica gel filler used has a good enrichment effect on the compound Phellibaumin D, the filler particle size is 5~200 mm, the pore size is 50~300 Å, and the compound Phellibaumin D crude product is enriched; (4) The crude compound Phellibaumin D is subjected to two-dimensional chromatography preparation and purification to obtain a high-purity compound Phellibaumin D. The chromatographic filler used is a high-density bonded C18TDE silica gel filler. The elution conditions are that one or both of methanol and ethanol are used as the organic phase and acid water is used as the aqueous phase as the mobile phase. The aqueous phase is one or both of formic acid or oxalic acid, with a volume ratio of 0.1-3.0%. The organic phase is 30-80% isocratic, 30-80% linear gradient or step gradient, the flow rate is 0.05-1.5 times the filler volume / min, the temperature is 10-60°C, the sample loading is 0.1-5.0%, the detector is a DAD ultraviolet detector, the elution time is 10-200 min, and the components of Phellibaumin D are collected according to the detector chromatographic peak curve. The obtained fractions are vacuum dried to obtain a compound Phellibaumin D with a purity of >90%; the high-density bonded C18TDE silica gel filler used in the two-dimensional preparation is used for the compound Phellibaumin D has good retention and good orthogonality with one-dimensional separation, which can separate and remove more impurities to obtain high-purity compound Phellibaumin D. The filler particle size is 5~200 mm and the pore size is 50~200 Å. The compound Phellibaumin D with a purity of >90% was prepared.

2. The method according to claim 1, characterized in that: The medicinal material of Phellinus igniarius is extracted with ethanol water having a volume concentration of 40-95%, with a mass volume ratio of the material to the liquid of 1:10-1:100, and the material is soaked for 1-48 hours; the material is then heated and boiled for extraction for 1-10 hours, and the alcohol extract is collected. The solid material is again repeatedly extracted with ethanol water at a mass volume ratio of the material to the liquid of 1:10-1:100, and the alcohol extract is collected. The extraction is repeated 1-5 times and the alcohol extracts are combined.

3. The method according to claim 1, characterized in that The alcohol extract was filtered through a ceramic membrane using membrane filtration technology. The pore size of the ceramic membrane filter element was 20-1000 nm, and the permeate was concentrated to a concentration of 1.0-200 mg / mL.